IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 48 filers reported holding IMMUNOCORE HLDGS PLC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $203,105,979 | -8.3% | 3,913,410 | +5.9% | 0.04% | -2.4% |
| Q2 2023 | $221,581,580 | +32.8% | 3,695,490 | +9.5% | 0.04% | +27.3% |
| Q1 2023 | $166,875,278 | +35.8% | 3,375,309 | +56.8% | 0.03% | +32.0% |
| Q4 2022 | $122,869,769 | +287.9% | 2,152,966 | +219.1% | 0.02% | +257.1% |
| Q3 2022 | $31,672,000 | -32.9% | 674,733 | -46.7% | 0.01% | -30.0% |
| Q2 2022 | $47,230,000 | +17.7% | 1,265,912 | -5.7% | 0.01% | +42.9% |
| Q1 2022 | $40,136,000 | -17.1% | 1,342,359 | -5.1% | 0.01% | -12.5% |
| Q4 2021 | $48,420,000 | +24.2% | 1,414,150 | +34.4% | 0.01% | +14.3% |
| Q3 2021 | $39,000,000 | +242.6% | 1,052,075 | +260.9% | 0.01% | +250.0% |
| Q2 2021 | $11,383,000 | +8.1% | 291,512 | +17.9% | 0.00% | 0.0% |
| Q1 2021 | $10,530,000 | – | 247,358 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $21,500,000 | 16.53% |
| Velan Capital Investment Management LP | 293,385 | $10,946,000 | 11.10% |
| Paradigm Biocapital Advisors LP | 667,417 | $24,901,000 | 4.96% |
| RTW INVESTMENTS, LP | 3,996,154 | $149,097,000 | 3.85% |
| Rock Springs Capital Management LP | 2,671,652 | $99,679,000 | 2.90% |
| TANG CAPITAL MANAGEMENT LLC | 385,600 | $14,387,000 | 2.18% |
| Samsara BioCapital, LLC | 160,963 | $6,006,000 | 1.60% |
| Avidity Partners Management LP | 1,350,000 | $50,369,000 | 1.16% |
| Pier Capital, LLC | 123,394 | $4,604,000 | 0.78% |
| Omega Fund Management, LLC | 51,535 | $1,923,000 | 0.61% |